Comments
Shares of drug firm Wockhardt surged over three per cent on bourses in early trade today after the UK health regulator confirmed that its manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).
On the BSE, the scrip opened at Rs 699 and jumped 3.24 per cent to an early high of Rs 704. At about 1.30 pm, it was trading 0.95 per cent or Rs 6.50 higher at Rs 688.40.
On the NSE, the stock opened at Rs 698.90 and rose 3.07 per cent to an early high of Rs 703.75. At about 1.30 pm, it was trading 0.63 per cent up at Rs 687.05.
In a BSE filing yesterday, Wockhardt said, “UK MHRA (UK Medicines and Healthcare products Regulatory Agency) has since confirmed that general compliance with the principles and guidelines of good manufacturing practice of the company’s manufacturing unit at L—1, Chikalthana, Aurangabad.”
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.